Published in Kardiologiia on October 01, 1978
[The effect of antihistaminic preparations on the binding of labelled mepyramine, ketanserin and quinuclidinyl benzilate in the rat brain]. Eksp Klin Farmakol (1993) 0.95
[Anticoagulant action and safety of warfarin dosing based on pharmacogenetic testing: results of the first Russian prospective pilot study]. Kardiologiia (2010) 0.84
[Effect of myocardial ischemia on adenine nucleotide metabolism]. Kardiologiia (1984) 0.83
Inhibition of plasma kallikrein. Kininase and kinin-like activities of preparations from the medicinal leeches. Thromb Res (1992) 0.82
[Reaction of N-alpha-tosyl-L-lysylchloromethane with kallikrein from blood plasma of rabbit and with kallikrein from urine and saliva of man]. Biokhimiia (1969) 0.81
[Carboxypeptidases (kininases) from human and rabbit serum--isolation, purification and properties]. Biokhimiia (1969) 0.81
[Activity of tissue and plasma kallikrein and level of their precursors in eye tissue structures and media of healthy rabbits]. Vopr Med Khim (1992) 0.80
The monoethylglycinexylidide (MEGX) test as a marker of hepatic dysfunction in septic patients with pneumonia. Clin Chem Lab Med (2000) 0.79
Sensitive high-performance liquid chromatographic determination of arbidol, a new antiviral compound, in human plasma. J Chromatogr A (1998) 0.78
[Kininogenase activity of cathepsins D]. Biokhimiia (1980) 0.77
[Various properties and kinetics of interaction of high and low molecular weight human kininogens with human plasma kallikrein]. Biokhimiia (1986) 0.77
[Uniform method for determining the alpha 1-antitrypsin and alpha 2-macroglobulin activity in human blood serum (plasma)]. Vopr Med Khim (1979) 0.76
[The influence of vitamin B group on monooxygenase activity of cytochrome P450 3A4: pharmacokinetics and electro analysis of catalytic properties]. Biomed Khim (2011) 0.76
Kininase of the Latrodectus tredecimguttatus venom: a study of its enzyme substrate specificity. Immunopharmacology (1996) 0.76
[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation]. Klin Med (Mosk) (2007) 0.75
Pheno- and genotyping the prescription of drugs metabolized by CYP2D6. Bull Exp Biol Med (2002) 0.75
[Effect of pyridinolcarbamate (parmidine) on some bradykinin effects]. Farmakol Toksikol (1976) 0.75
[Pharmacological properties of sydnophen]. Farmakol Toksikol (1972) 0.75
[Color reaction between RNA, its hydrolysis products and some physiologically active aromatic amines]. Vopr Med Khim (1971) 0.75
[Influence of antidepressants on the hypothermic effects of alpha-methyldopa and clofelin]. Farmakol Toksikol (1983) 0.75
[Effect of the beta-adrenoblockader atenolol on the extent of myocardial necrosis in transient and permanent coronary occlusion]. Biull Eksp Biol Med (1984) 0.75
[Terms used for denoting drugs]. Farmatsiia (1974) 0.75
[Influence of antidepressants on benzodiazepine (diazepam and nitrazepam) effects]. Farmakol Toksikol (1989) 0.75
[Effect of xanthine derivatives on thrombocyte aggregation and other hemostatic indices]. Biull Eksp Biol Med (1980) 0.75
[Synthesis, pharmacological properties and effect upon monoamine oxidase activity of some sydnoneimines]. Farmakol Toksikol (1970) 0.75
[Experimental study of the antihypoxic properties of ibuprofen and other nonsteroidal anti-inflammatory preparations]. Biull Eksp Biol Med (1987) 0.75
[Pharmacological properties of new antidepressive agent azaphen]. Farmakol Toksikol (1970) 0.75
[Effect of antidepressants of different groups on the cholinergic structures of the brain]. Zh Nevropatol Psikhiatr Im S S Korsakova (1981) 0.75
[On the pharmacology of tegretol]. Farmakol Toksikol (1969) 0.75
[Pharmacological properties of some 5-oxytryptamine salts]. Farmakol Toksikol (1970) 0.75
[Main peculiarities of the draft of the new (X) edition of the State Pharmacopoeia of the USSR]. Med Prom SSSR (1965) 0.75
[Progress of pharmacology and difficulties of pharmacotherapy]. Ter Arkh (1975) 0.75
[Urgent problems of research and clinico-pharmacological studies of new drugs]. Ter Arkh (1976) 0.75
[Adrenergic mechanisms of antidepressant action]. Zh Nevropatol Psikhiatr Im S S Korsakova (1970) 0.75
[Effect of ketamine on the evoked potentials of the somatosensory and visual cortices of the rabbit brain]. Farmakol Toksikol (1988) 0.75
[Effect of atenolol and propranolol on systemic and regional hemodynamics]. Biull Eksp Biol Med (1983) 0.75
[Effect of the antihistamine preparation, phencarol, on the central nervous system]. Farmakol Toksikol (1981) 0.75
[Effect of antihistaminic preparations on gastric secretion in rats]. Biull Eksp Biol Med (1983) 0.75
[Sydnocarb--new central nervous system stimulator]. Farmakol Toksikol (1973) 0.75
[Role of transmembrane ion currents in the mechanism of action of beta-adrenoblockers]. Biull Eksp Biol Med (1984) 0.75
[Effect of several anti-arrhythmic substances on ion currents in from atrium]. Farmakol Toksikol (1979) 0.75
[Interaction of antidepressants and anticonvulsants in anticonvulsive and anti-reserpine tests]. Biull Eksp Biol Med (1986) 0.75
[Comparative mydriatic effect of different groups of antidepressants]. Farmakol Toksikol (1981) 0.75
[Study of antiserotonin and antihistaminic properties of some derivatives of 1,10-trimethylenepyrazino-(1,2-a)-indole]. Farmakol Toksikol (1969) 0.75
[Pharmacological properties and clinical use of xanthinol nicotinate]. Klin Med (Mosk) (1984) 0.75
[Effect of azaphen on the bioelectric activity of the brain]. Farmakol Toksikol (1971) 0.75
[The influence of serotonin on blood flow volume and pO2 in various regions of the brain]. Biull Eksp Biol Med (1967) 0.75
[Enkephalins and endorphins--a new class of biogenic physiologically active substances]. Ter Arkh (1978) 0.75
[Comparative effect of antiglaucoma preparations on brain bioelectrical activity]. Farmakol Toksikol (1983) 0.75
[Comparative cholinolytic activity of amizil, aprophen and of their corresponding quinuclidine esters]. Farmakol Toksikol (1968) 0.75
[Comparative pharmacological study of analogs and derivatives of tropacin]. Farmakol Toksikol (1973) 0.75
[10th education of the State Pharmacopeia of the USSR]. Farmatsiia (1969) 0.75
[Curare-like activity of the analogues of diplacin]. Farmakol Toksikol (1968) 0.75
[Cholinolytic properties of the alpha,alpha-di-(2-thienyl)- and alpha-phenyl-alpha-(2-thienyl)-glycolic esters of 3-oxyquinuclidine]. Farmakol Toksikol (1975) 0.75
[Study of the mechanism of action of the new antidepressant pyrazidol]. Farmakol Toksikol (1976) 0.75
[Effect of the antihistamine preparation, fencarol, and other quinuclidyldiarylcarbinols on tissue aminoxidase activity]. Farmakol Toksikol (1980) 0.75
[Comparative anorexigenic activity and other pharmacological properties of quipazine and its N-acyl derivatives]. Farmakol Toksikol (1986) 0.75
[Pharmacology of some carbamoyl derivatives of serotonin]. Farmakol Toksikol (1971) 0.75
[Pharmacological properties of peptide derivatives of 5-methoxytrayptamine]. Farmakol Toksikol (1968) 0.75
[Distribution of different groups of indirect sympathomimetics between aqueous and "fatty" phases]. Farmakol Toksikol (1977) 0.75
[Study of antimonoamine oxidase action and pharmacological properties of 2,3-dihydro-1H-benz[d,e]isoquinoline hydrochloride]. Farmakol Toksikol (1975) 0.75
[Experimental study of the antihypertensive activity of unithiol, D-penicillamine and cysteine]. Farmakol Toksikol (1984) 0.75
[Some indices of effect of acridine orange and proflavine on the central nervous system]. Farmakol Toksikol (1969) 0.75
[An experimental study of the psychotropic action of pyrazidol]. Farmakol Toksikol (1975) 0.75
[Inhibition of brain monoamine oxidase in the rat by multiple pyrazidol administration]. Biull Eksp Biol Med (1985) 0.75
[Beta-adrenoblocking activity and other pharmacological properties of 2-(3-amino-2-hydroxypropoxy)phenyoxymethyl isoxazole derivatives]. Farmakol Toksikol (1985) 0.75
[Comparative effect of central cholinolytics amisyl, aprophen and corresponding quinuclidine esters on conditioned reflex activity and behavior of rats]. Farmakol Toksikol (1969) 0.75
[Fenkarol and its use in the therapy of allergic diseases]. Klin Med (Mosk) (1978) 0.75
[Pharmacological properties of typical and atypical antidepressants in single and repeated administration]. Farmakol Toksikol (1985) 0.75
[Pharmacological properties of 3-methyl-3,9-diazabicyclo(3,3,1) nonane derivatives of 2-chlorophenothiazine]. Farmakol Toksikol (1972) 0.75
[Blocking of the peripheral adrenergic systems in application to the regulation of blood circulation]. Vestn Akad Med Nauk SSSR (1966) 0.75
[The 10th edition of the USSR Government Pharmacopaeian]. Farmatsiia (1970) 0.75
[Characteristics of the pharmacological action of piracetam]. Farmakol Toksikol (1978) 0.75
[Experimental and clinical characteristics of the Soviet antidepressant inkasan]. Zh Nevropatol Psikhiatr Im S S Korsakova (1984) 0.75
[Biological aspects and the developmental prospects of modern psychopharmacology]. Vestn Akad Med Nauk SSSR (1979) 0.75
[Antiserotonin and antihistaminic properties of dialkylaminoalkyl derivatives of 2-methyl-5-oxyindole]. Farmakol Toksikol (1968) 0.75
[Effect of parmidine (pyridinolcarbamate) on thrombocyte aggregation, blood clotting and fibrinolysis]. Biull Eksp Biol Med (1976) 0.75
[Effect of indopan on cerebral circulation]. Farmakol Toksikol (1969) 0.75
[Theoretical and practical bases of the search for psychotropic preparations]. Vestn Akad Med Nauk SSSR (1976) 0.75
[Interaction of sydnocarb with preparations influencing the metabolism of catecholamines]. Farmakol Toksikol (1976) 0.75
[Scientific and technical progress and clinical pharmacology]. Klin Med (Mosk) (1986) 0.75
[Comparative pharmacological study of a series of new antidepressants]. Farmakol Toksikol (1982) 0.75
[Effect of prazosin on human prostatic adenoma tissue]. Biull Eksp Biol Med (1988) 0.75
[Pharmacological activity of the optical isomers of sydnocarb]. Farmakol Toksikol (1981) 0.75
[Current approaches to the development of new pharmacologically active (medicinal) substances]. Vestn Akad Med Nauk SSSR (1982) 0.75
[Pharmacological properties of some tryptamine homologues]. Farmakol Toksikol (1972) 0.75
[Clinical use of dopamine in intensive therapy]. Klin Med (Mosk) (1988) 0.75
[Effect of dihydroergotamine on the change in tonus of the cerebral vessels, caused by serotonin]. Farmakol Toksikol (1969) 0.75
[Antihistaminic and antiserotonin properties of new complex tropine esters]. Farmakol Toksikol (1979) 0.75
[Selective inhibition by pyrazidol of monoamine oxidase type A in different human and animal tissues]. Vopr Med Khim (1984) 0.75
[Antiarrhythmic effect of oxylidine]. Farmakol Toksikol (1970) 0.75
[Experimental and clinical study of a new psychic energizer Sydnocarb]. Zh Nevropatol Psikhiatr Im S S Korsakova (1971) 0.75
[Pharmacology and scientific and technical progress]. Farmakol Toksikol (1985) 0.75
[Stages in the development of Soviet neuropharmacology]. Farmakol Toksikol (1988) 0.75
[Pavlovian principles of nervosism and the importance of modern neuropharmacologic drugs to medicine]. Vestn Akad Med Nauk SSSR (1986) 0.75
[Pharmacological properties and clinical use of clofelin]. Klin Med (Mosk) (1979) 0.75
[Effect of the tetracyclic antidepressants pyrazidol and inkazan on the adrenergic nerve transmission in the rat vas deferens]. Farmakol Toksikol (1982) 0.75
[Characteristic pharmacological properties of a number of antidepressants in repeated administration]. Farmakol Toksikol (1984) 0.75
[The pharmacologic basis of the antidepressive activity of the new psychotropic preparation pyrazidol]. Zh Nevropatol Psikhiatr Im S S Korsakova (1975) 0.75
[Experimental study of the anti-inflammatory action of pyridinolcarbamate]. Farmakol Toksikol (1976) 0.75